Literature DB >> 33097914

Improving data sharing to increase the efficiency of antibiotic R&D.

Wes Kim, Kevin Krause, Zak Zimmerman, Kevin Outterson.   

Abstract

Year:  2021        PMID: 33097914     DOI: 10.1038/d41573-020-00185-y

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

1.  Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety.

Authors:  Frederick Cohen; James B Aggen; Logan D Andrews; Zahra Assar; Jen Boggs; Taylor Choi; Paola Dozzo; Ashton N Easterday; Cat M Haglund; Darin J Hildebrandt; Melissa C Holt; Kristin Joly; Adrian Jubb; Zeeshan Kamal; Timothy R Kane; Andrei W Konradi; Kevin M Krause; Martin S Linsell; Timothy D Machajewski; Olga Miroshnikova; Heinz E Moser; Vincent Nieto; Thu Phan; Craig Plato; Alisa W Serio; Julie Seroogy; Anton Shakhmin; Adam J Stein; Alex D Sun; Serguei Sviridov; Zhan Wang; Kenneth Wlasichuk; Wen Yang; Xiaoming Zhou; Hai Zhu; Ryan T Cirz
Journal:  ChemMedChem       Date:  2019-08-05       Impact factor: 3.466

Review 2.  LpxC inhibitors: a patent review (2010-2016).

Authors:  Dmitrii V Kalinin; Ralph Holl
Journal:  Expert Opin Ther Pat       Date:  2017-08-04       Impact factor: 6.674

3.  Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Kevin M Krause; Cat M Haglund; Christy Hebner; Alisa W Serio; Grace Lee; Vincent Nieto; Frederick Cohen; Timothy R Kane; Timothy D Machajewski; Darrin Hildebrandt; Chris Pillar; Mary Thwaites; Danielle Hall; Lynn Miesel; Meredith Hackel; Amanda Burek; Logan D Andrews; Eliana Armstrong; Lee Swem; Adrian Jubb; Ryan T Cirz
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 4.  Antibiotics in the clinical pipeline in October 2019.

Authors:  Mark S Butler; David L Paterson
Journal:  J Antibiot (Tokyo)       Date:  2020-03-10       Impact factor: 2.649

  4 in total
  7 in total

Review 1.  Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview.

Authors:  Tapan Behl; Gabriele Rocchetti; Swati Chadha; Gokhan Zengin; Simona Bungau; Arun Kumar; Vineet Mehta; Md Sahab Uddin; Gaurav Khullar; Dhruv Setia; Sandeep Arora; Kouadio Ibrahime Sinan; Gunes Ak; Predrag Putnik; Monica Gallo; Domenico Montesano
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-19

Review 2.  The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery.

Authors:  Maria Gagliardi; Ana Tari Ashizawa
Journal:  Biomedicines       Date:  2021-04-16

Review 3.  Silencing Antibiotic Resistance with Antisense Oligonucleotides.

Authors:  Saumya Jani; Maria Soledad Ramirez; Marcelo E Tolmasky
Journal:  Biomedicines       Date:  2021-04-12

Review 4.  Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020.

Authors:  Neha K Prasad; Ian B Seiple; Ryan T Cirz; Oren S Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  2022-04-26       Impact factor: 5.938

Review 5.  TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs.

Authors:  Sun-Young Han
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-29

Review 6.  Accelerating antibiotic discovery through artificial intelligence.

Authors:  Marcelo C R Melo; Jacqueline R M A Maasch; Cesar de la Fuente-Nunez
Journal:  Commun Biol       Date:  2021-09-09

7.  There is no market for new antibiotics: this allows an open approach to research and development.

Authors:  Dana M Klug; Fahima I M Idiris; Mark A T Blaskovich; Frank von Delft; Christopher G Dowson; Claas Kirchhelle; Adam P Roberts; Andrew C Singer; Matthew H Todd
Journal:  Wellcome Open Res       Date:  2021-06-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.